Viemed Healthcare, Inc. (VMD) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.
Analysts estimate Earnings Per Share (EPS) of $0.28 and revenue of $0.22B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.29 vs est $0.28 (beat +3.6%). 2025: actual $0.38 vs est $0.40 (missed -4.2%). Analyst accuracy: 96%.
VMD Analyst Ratings
Buy
Based on 1 analysts giving stock ratings to Viemed Healthcare, Inc. in the past 3 months
EPS Estimates — VMD
96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.29
vs Est $0.28
▲ 3.4% off
2025
Actual $0.38
vs Est $0.40
▼ 4.4% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is improving.
Revenue Estimates — VMD
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.224B
vs Est $0.224B
▲ 0.2% off
2025
Actual $0.270B
vs Est $0.272B
▼ 0.6% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
